DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ advanced 1.11% to $709.21 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.41% to 7,200.75 and Dow Jones Industrial Average falling 1.13% to 48,941.90.
Regeneron Pharmaceuticals Inc. closed 13.63% short of its 52-week high of $821.11, which the company reached on January 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Amgen Inc. $(AMGN)$ fell 1.81% to $323.85, Moderna Inc. (MRNA) rose 4.25% to $47.30, and Gilead Sciences Inc. (GILD) rose 0.79% to $132.69.
Trading volume (553,808) remained 117,660 below its 50-day average volume of 671,468.
Data source: Dow Jones Market Data, FactSet. Data compiled May 4, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 04, 2026 16:44 ET (20:44 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments